| Symbol | Price | Change | % Change |
|---|
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Timothy Arcuri UBS | Buy | Reiterated | $280.00 | +24.4% | 08/14/2026 |
Joseph Moore Morgan Stanley | Buy | Maintained | $288.00 | +27.9% | 08/14/2026 |
James Schneider Goldman Sachs | Buy | Reiterated | $285.00 | +26.6% | 08/12/2026 |
Christopher Rolland Susquehanna | Buy | Reiterated | $275.00 | +22.1% | 08/12/2026 |
Aaron Rakers Wells Fargo | Buy | Reiterated | $315.00 | +39.9% | 08/11/2026 |
Srini Pajjuri RBC Capital | Buy | Maintained | $300.00 | +33.2% | 08/11/2026 |
Vivek Arya Bank of America Securities | Buy | Reiterated | $350.00 | +55.4% | 08/11/2026 |
Varun Govindaraj Bernstein | Buy | Maintained | $315.00 | +39.9% | 08/03/2026 |
Stacy Rasgon Bernstein | Buy | Maintained | $315.00 | +39.9% | 07/27/2026 |
Ingo Wermann DZ BANK AG | Buy | Maintained | - | - | 07/22/2026 |
William Stein Truist Financial | Buy | Reiterated | - | - | 07/21/2026 |
Atif Malik Citi | Buy | Maintained | $300.00 | +33.2% | 07/14/2026 |
John Vinh KeyBanc | Buy | Maintained | $330.00 | +46.6% | 07/14/2026 |
Joshua Buchalter TD Cowen | Buy | Maintained | $275.00 | +22.1% | 07/08/2026 |
Dien Wang Bernstein | Buy | Maintained | $315.00 | +39.9% | 06/29/2026 |
Rick Schafer Oppenheimer | Buy | Maintained | $265.00 | +17.7% | 06/12/2026 |
Fang Boon Foo DBS | Buy | Maintained | $250.00 | +11% | 06/05/2026 |
Vijay Rakesh Mizuho Securities | Buy | Reiterated | - | - | 06/03/2026 |
Chris Caso Wolfe Research | Buy | Maintained | $275.00 | +22.1% | 06/02/2026 |
Quinn Bolton Needham | Buy | Maintained | $270.00 | +19.9% | 06/02/2026 |
Sebastien Naji William Blair | Buy | Reiterated | - | - | 06/02/2026 |
Gil Luria D.A. Davidson | Buy | Reiterated | $300.00 | +33.2% | 06/01/2026 |
Ivan Feinseth Tigress Financial | Buy | Reiterated | $425.00 | +88.8% | 05/27/2026 |
Ruben Roy Stifel Nicolaus | Buy | Maintained | $282.00 | +25.2% | 05/25/2026 |
Yik Ban Chong Phillip Securities | Buy | Maintained | $285.00 | +26.6% | 05/24/2026 |
Richard Shannon Craig-Hallum | Buy | Maintained | $275.00 | +22.1% | 05/21/2026 |
Simon Leopold Raymond James | Buy | Maintained | $330.00 | +46.6% | 05/21/2026 |
Daniel Ives Wedbush | Buy | Reiterated | $330.00 | +46.6% | 05/21/2026 |
Matt Bryson Wedbush | Buy | Reiterated | $330.00 | +46.6% | 05/21/2026 |
Harlan Sur J.P. Morgan | Buy | Reiterated | $280.00 | +24.4% | 05/21/2026 |
C J Muse Cantor Fitzgerald | Buy | Reiterated | $350.00 | +55.4% | 05/20/2026 |
Tristan Gerra Robert W. Baird | Buy | Maintained | $500.00 | +122.1% | 05/21/2026 |
Cody Acree Benchmark Co. | Buy | Maintained | $335.00 | +48.8% | 05/21/2026 |
Ross Seymore Deutsche Bank | Hold | Maintained | $255.00 | +13.3% | 05/21/2026 |
Thomas O'Malley Barclays | Buy | Reiterated | $275.00 | +22.1% | 05/21/2026 |
Blayne Curtis Jefferies | Buy | Reiterated | $300.00 | +33.2% | 05/22/2026 |
Jim Kelleher Argus Research | Buy | Reiterated | $270.00 | +19.9% | 05/20/2026 |
Kevin Cassidy Rosenblatt Securities | Buy | Maintained | $325.00 | +44.3% | 05/21/2026 |
Mark Lipacis Evercore ISI | Buy | Reiterated | $413.00 | +83.4% | 05/19/2026 |
Frank Lee CFA HSBC | Buy | Maintained | $325.00 | +44.3% | 05/19/2026 |
David Siffringer Cantor Fitzgerald | Buy | Reiterated | $350.00 | +55.4% | 05/14/2026 |
David Dai CFA Bernstein | Buy | Maintained | $300.00 | +33.2% | 05/08/2026 |
Ben Reitzes Melius Research | Buy | Reiterated | $380.00 | +68.8% | 03/16/2026 |
Jay Goldberg Seaport Global | Sell | Reiterated | - | - | 03/16/2026 |
Bhavtosh Vajpayee CLSA | Buy | Maintained | $300.00 | +33.2% | 03/04/2026 |
Harsh Kumar Piper Sandler | Buy | Reiterated | $225.00 | -0.1% | 02/26/2026 |
Stefan Chang Aletheia Capital | Buy | Upgraded | $250.00 | +11% | 02/23/2026 |
All values in USD | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 |
|---|---|---|---|---|
Revenue | 46.74B | 57.01B | 68.13B | 81.62B |
Cost of goods sold | 12.89B | 15.16B | 17.03B | 20.46B |
Cost of revenue | 12.89B | 15.16B | 17.03B | 20.46B |
Research and development expenses | 4.29B | 4.70B | 5.51B | 6.32B |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 1.12B | 1.13B | 1.28B | 1.30B |
Operating expense | 5.41B | 5.84B | 6.79B | 7.62B |
Total operating expenses | 18.30B | 21.00B | 23.83B | 28.08B |
Operating income | 28.44B | 36.01B | 44.30B | 53.54B |
Other non operating income | 1.97B | 9.00M | 112.00M | -7.00M |
EBT including unusual items | 31.21B | 37.94B | 50.40B | 69.90B |
EBT excluding unusual items | 30.94B | 36.58B | 44.91B | 53.97B |
Income tax expense | 4.78B | 6.03B | 7.44B | 11.58B |
Effective tax rate | 15.33% | 15.88% | 14.76% | 16.57% |
Other operating expenses | - | - | - | - |
Net income | 26.42B | 31.91B | 42.96B | 58.32B |
Net profit margin | 56.53% | 55.98% | 63.06% | 71.46% |
Earnings per share | 1.05 | 1.30 | 1.62 | 1.87 |
Interest and investment income | 592.00M | 624.00M | 568.00M | 540.00M |
Interest expense | -62.00M | -61.00M | -73.00M | -102.00M |
Net interest expenses | 530.00M | 563.00M | 495.00M | 438.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 29.11B | 36.76B | 45.11B | 54.53B |
Gain or loss from assets sale | - | - | - | - |
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|